Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03932799 · ClinicalTrials.gov registry record
Comparing State Payer Strategies to Prevent Unsafe Opioid Prescribing
A clinical trial of Opioid Use and Opioid-Related Disorders, sponsored by University of Washington.
- Completed
- Registry status
- 5,411
- Enrollment target
- 2
- Study locations
NCT03932799 is a study of Opioid Use and Opioid-Related Disorders that has completed, run by University of Washington. The registered enrollment target is 5,411 participants, below the 148,209-participant average among 105 other Opioid Use trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03932799, a study of Opioid Use and Opioid-Related Disorders, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 5,411 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study examines the comparative effectiveness of opioid review programs in reducing unsafe opioid prescribing in two states: prospective prior authorization (PA) with hard stops in Washington and retrospective review (RR) with prescriber notification in Ohio.
Conditions Studied
Interventions
- OTHER Prospective prior authorization (PA) with hard stops in Washington
- OTHER Retrospective review (RR) with prescriber notification in Ohio
Study Locations (2)
Ohio
- The Ohio State University - Columbus
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,411 participants |
| Start Date | 2019-08-06 |
| Est. Completion | 2022-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03932799
The ClinicalTrials.gov registry entry for NCT03932799 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,411 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,209-participant average among 105 other Opioid Use trials with a reported enrollment target (96% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Opioid Use appearing as the primary indexed condition, and to 2 interventions - of which Prospective prior authorization (PA) with hard stops in Washington is the first listed.
NCT03932799 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Washington.
Frequently Asked Questions
What is clinical trial NCT03932799 about?
NCT03932799 is a clinical study titled "Comparing State Payer Strategies to Prevent Unsafe Opioid Prescribing". This study examines the comparative effectiveness of opioid review programs in reducing unsafe opioid prescribing in two states: prospective prior authorization (PA) with hard stops in Washington and retrospective review (RR) with prescriber notification in Ohio.
What is the current status of trial NCT03932799?
This trial is currently completed. The enrollment target is 5,411 participants. The study started on 2019-08-06. Estimated completion is 2022-06-30.
What conditions does trial NCT03932799 study?
This clinical trial studies the following conditions: Opioid Use, Opioid-Related Disorders.
What interventions are being tested in trial NCT03932799?
The interventions under investigation include: Prospective prior authorization (PA) with hard stops in Washington (OTHER), Retrospective review (RR) with prescriber notification in Ohio (OTHER).
Who is sponsoring clinical trial NCT03932799?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03932799 being conducted?
This trial has 2 study locations across Ohio, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
RECRUITING · Phase 3
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
QL vs LAI for Palatoplasty
RECRUITING · NA
-
Opioid Use After Laparoscopic Salpingectomy
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.